ARC Capital in the Australia-China biotech invest

ARC Capital in the Australia-China biotech invest

Last Monday, ARC Capital was involved in the Australia-China biotech invest 2017, the place to find Biotech innovators from around the world and partnership opportunities. with leading-edge technologies.

The program took place on Monday 27 March at the Marriott in Shanghai. The program featured company presentations, keynote speakers, lively panel discussions and was the perfect location for us to meet potential clients.

We discuss with the following companies in order to cooperate together:

  • Petri Exchange
  • Biotron
  • Novogen
  • FivepHusion
  • ResApp

The upcoming partnerships is an indication of ARC Capital’s capabilities to assist both public and private listed companies.

Continue reading

Alarar Capital Group Securities Adds Underwriting License, Strengthening Global Capital Markets Platform

Alarar Capital Group Securities Adds Underwriting License, Strengthening Global Capital Markets Platform

Alarar Capital Group Securities LLC (“ARC Securities”), a wholly owned subsidiary of Alarar Capital Group, is pleased to announce that it has received approval from the Financial Industry Regulatory Authority (FINRA) to operate as a registered underwriting broker-dealer in the United States. This milestone marks a significant step in ARC Securities’ ongoing expansion of its global capital […]
Alarar Capital Group Appointed as Exclusive Financial Advisor to XRP Healthcare M&A Holding Inc. on Definitive Agreement for Proposed Qualifying Transaction with AAJ Capital 3 Corp.
Alarar Capital Group Joins Celebration of the Best Workplaces™ in Hong Kong 2025

Please complete this form to download the case study

This field is for validation purposes and should be left unchanged.
*Required before submission